… Thus, corticosteroids and immune-mediated adverse events were highly unlikely to influence
the association of ICI treatment with COVID-19 severity reported in this study. The findings …

Context.— An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

… factors for disease severity. COVID-19 patients with lymphopenia have longer length of
hospital stay. In addition, our data do not support corticosteroid treatment for COVID-19 patients. …

… (Tregs) is suggested to contribute in the pathogenesis of COVID-19. CD4+ T cells are divided
into different … The correlation of these cytokines with the disease severity was also shown. …

… and the treatment and prevention of COVID-19 helps to … predictor of disease outcome,
COVID-19 disease severity is not … N/A In the first period of covid-19 outbreak viral load was higher …

… as mediators of COVID‐19‐associated pathogenesis. The objective of this study was to
understand the contribution of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

… is very important for the grading treatment of patients. In … to conduct grading severity and
treatment, thereby optimize the … of the national treatment guideline, COVID-19 can be classified …

… at the Fifth Medical Center of Chinese PLA General Hospital was designated to be one of
the medical institutions for the diagnosis and treatment of patients with COVID-19 in Beijing, …

… Understanding innate immune responses in coronavirus disease 2019 (COVID-19) is
important to decipher mechanisms of host responses and interpret disease pathogenesis. Natural …

… , early identification of disease severity and interpretation of pathogenesis are very important…
of cytokines in COVID-19 were significantly correlated with the severity of the disease in the …